Analysis of Medicare Patients Treated with Pimavanserin versus Other Atypical Antipsychotics: A Cost-Offset Model Evaluating Skilled Nursing Facility Stays and Long-Term Care Admissions in Parkinson’s Disease Psychosis

Analysis of Medicare Patients Treated with Pimavanserin versus Other Atypical Antipsychotics: A Cost-Offset Model Evaluating Skilled Nursing Facility Stays and Long-Term Care Admissions in Parkinson’s Disease Psychosis

Krithika Rajagopalan,1 Nazia Rashid,2 Vinod Yakkala,1 Dilesh Doshi2 1Anlitiks Inc., Windermere, FL, USA; 2Medical Affairs, Acadia Pharmaceuticals Inc., San Diego, CA, USACorrespondence: Krithika Rajagopalan, Anlitiks Inc., Email kr.rajagopalan@anlitiks.comBackground: Patients with Parkinson’s diseas...

Full description

Bibliographic Details
Main Authors: Rajagopalan K, Rashid N, Yakkala V, Doshi D
Format: Article
Language:English
Published: Dove Medical Press 2024-03-01
Series:ClinicoEconomics and Outcomes Research
Subjects:
nursing homes
psychosis
quetiapine
rehabilitation costs
cost savings
Online Access:https://www.dovepress.com/analysis-of-medicare-patients-treated-with-pimavanserin-versus-other-a-peer-reviewed-fulltext-article-CEOR

Internet

https://www.dovepress.com/analysis-of-medicare-patients-treated-with-pimavanserin-versus-other-a-peer-reviewed-fulltext-article-CEOR

Similar Items